Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than ...

Psoriasis is often considered to be a skin condition, but it’s actually a systemic disease that can lead to symptoms such as ...

The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for the treatment of plaque ...

The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis of the scalp and ...